CLOPIDOGREL
Clopierra

CLOPIERRA is indicated as an antiplatelet drug for the prophylactic treatment of patients with atherosclerosis who are at risk of thromboembolic disorders, such as myocardial infarction, peripheral arterial disease, and stroke. It is also indicated for use with aspirin in acute coronary syndromes, including acute myocardial infarction and unstable angina, and in patients undergoing coronary stenting.

Packaging: box of 100’s
Shelf Life: 36 months
Origin: India
Dosage Form: FILM-COATED TABLET